Get started
RedHotStocks

Jefferies initiated Relmada Therapeutics with buy $75 target

Long
Relmada Therapeutics, Inc. (NASDAQ:RLMD)  
RedHotStocks  
NASDAQ:RLMD   Relmada Therapeutics, Inc.
Trend Analysis Chart Patterns Technical Indicators
28
0
trendanalysis chartpattern indicator
Jefferies analyst Andrew Tsai initiated coverage of Relmada Therapeutics with a Buy rating and $75 price target.
Bullish indicators and price action.
Nice channel developed to trade.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.